HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The behavior of hepatic phosphorylase b kinase, phosphorylase a and b after administration of glucagon to patients with glycogen storage disease type VIa.

Abstract
In the patients with glycogen storage disease (GSD) type VIa and different serum glucose response to glucagon, the activities of hepatic phosphorylase b kinase, phosphorylase a and b were estimated before and after the intravenous administration of glucagon. 3 min after the administration of glucagon an increase in the activities of phosphorylase b kinase and phosphorylase a was found in liver tissue of all patients except one. These enzymatic activities, however, did not exceed the values of these enzymes in the control liver biopsies without glucagon loading. After the intravenous administration of glucagon an unsuspected increase of phosphorylase b activity was observed in the control liver tissues and in patients with GSD type VIa, except one. In vitro investigations revealed that an increase of hepatic phosphorylase b activity occurs during its conversion to phosphorylase a. We suppose that this phosphorylase b represents a partially phosphorylated form of this enzyme (an intermediate form) that is due to the action of the active phosphorylase b kinase. The correlations between the activities of phosphorylase b kinase, phosphorylase a and an intermediate form of phosphorylase b and hepatic glycogen degradation after administration of glucagon has been discussed.
AuthorsD Pieniazek, E Pronicka, J Pawłowska
JournalHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme (Horm Metab Res) Vol. 18 Issue 8 Pg. 546-50 (Aug 1986) ISSN: 0018-5043 [Print] Germany
PMID3093350 (Publication Type: Journal Article)
Chemical References
  • Glucagon
  • Phosphorylase a
  • Phosphorylase b
  • Phosphorylases
  • Phosphorylase Kinase
Topics
  • Child, Preschool
  • Glucagon (administration & dosage, pharmacology)
  • Glycogen Storage Disease (enzymology)
  • Glycogen Storage Disease Type VI (enzymology, metabolism)
  • Humans
  • Injections, Intravenous
  • Liver (enzymology)
  • Male
  • Phosphorylase Kinase (metabolism)
  • Phosphorylase a (metabolism)
  • Phosphorylase b (metabolism)
  • Phosphorylases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: